Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Fish Litigation Blog

Welcome to the Fish & Richardson litigation blog, a community site where our intellectual property, commercial, and white collar litigators share information on nationwide litigation developments and trends. Join the conversation!

Fish Litigation Blog
Filter blogs by
Webinars

Fish Litigation Blog

The depth and breadth of Fish’s litigation practice is constantly expanding to fit the needs of our clients and the realities of the economic, business, and technological challenges they face. Our litigation blog reflects the full expanse of our litigation practice. Among other things, we discuss: developments in patent and trademark litigation, intricacies associated with ITC proceeding, Federal Circuit summaries and Supreme Court decisions, how courts are handling NPE litigation, various manifestations of the America Invents Act (AIA), commercial and business litigation matters, the Delaware Court of Chancery, and white collar defense and government investigation issues.

q&a ad

Welcome to the conversation!

Webinars Ad


IP Litigation, Life Sciences
July 26, 2016
Amgen DJ to Compel Patent Dance Dismissed
Authors: Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation, Life Sciences
July 25, 2016
Can Reference Product Sponsor Forfeit Right To Sue Under BPCIA?
Authors: Brian D. Coggio, Ron Vogel
IP Litigation, Life Sciences
July 14, 2016
Fall-Out from the Federal Circuit’s Decision in Amgen v. Apotex
Authors: Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D., Alex Pechette
IP Litigation
July 11, 2016
Notice of Commercialization Is Only Effective After FDA-Approval Regardless of Whether Parties Dance
Authors: Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation
June 24, 2016
Patent Litigation for the Non-Specialist: How it Works and What to Expect
Authors: Jolynn M. Lussier, Adam Kessel, Lawrence K. Kolodney
IP Litigation, Life Sciences
June 22, 2016
Amgen v. Sandoz SCOTUS Appeal on Hold Until October
Authors: Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D., Alex Pechette
IP Litigation
June 21, 2016
Supreme Court Affirms the Federal Circuit’s Very Limited Review of Post-Grant Institution Decisions and the Patent Office’s “Broadest Reasonable Interpretation” Claim Construction Standard
Author: John A. Dragseth
IP Litigation, Life Sciences
June 17, 2016
Janssen Uses Manufacturing Info Obtained in BPCIA Litigation to Target Supplier
Authors: Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D., Alex Pechette
IP Litigation, Life Sciences
June 15, 2016
Amgen v. Sandoz—The Biosimilars Battle Continues
Authors: Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D., Sarah Jack
IP Litigation, Life Sciences
June 15, 2016
Live From the ACI Biosimilar Conference
Author: Tasha M. Francis, Ph.D.
IP Litigation
June 14, 2016
Enhanced Damages in Patent Cases to Depend on All Relevant Circumstances for "Egregious" Behavior
Authors: William R. Woodford, John A. Dragseth
load more posts

Stay current with Fish Sign up for our Newsletter